COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,001 Articles (22,627 medRxiv, 8,374 bioRxiv)

Most recent first Previous |  Page 1702: Articles 17011-17020  | Next

What level of neutralising antibody protects from COVID-19? .
Khoury, D. S., Cromer, D., Reynaldi, A., Schlub, T. E., Wheatley, A. K., Juno, J. A., Subbarao, K., Kent, S. J., Triccas, J. A., Davenport, M. P.
10.1101/2021.03.09.21252641 — Posted: 2021-03-11
Predicting the Efficacy of COVID-19 Convalescent Plasma Donor Units with the Lumit Dx anti-Receptor Binding Domain Assay.
Janaka, S. K., Clark, N. M., Evans, D. T., Connor, J. P.
10.1101/2021.03.08.21253135 — Posted: 2021-03-11
High-resolution epigenome analysis in nasal samples derived from children with respiratory viral infections reveals striking changes upon SARS-CoV-2 infection
Winkley, K., Koseva, B., Banerjee, D., Cheung, W., Selvarangan, R., Pastinen, T., Grundberg, E.
10.1101/2021.03.09.21253155 — Posted: 2021-03-11
Exploring the short-term role of particulate matter in the COVID-19 outbreak in USA cities
Yoshiaki Kamigauti, L., Martins Palma Perez, G., Souto-Oliveira, C. E., Cowdery, E., Nascimento Saldiva, P. H., Andrade, M. d. F.
10.1101/2021.03.09.21253212 — Posted: 2021-03-11
Point-of-care ultrasonography for risk stratification of non-critical suspected COVID-19 patients on admission (POCUSCO): a prospective binational study
Morin, F., Douillet, D., Hamel, J. F., Savary, D., Aube, C., Tazarourte, K., Marouf, K., Dupriez, F., Le Conte, P., Flament, T., Delomas, T., Taalba, M., Marjanovic, N., Couturaud, F., Peschanski, N., Boishardy, T., Riou, J., Dubee, V., Roy, P.-M.
10.1101/2021.03.09.21253208 — Posted: 2021-03-11
Functional Antibodies in COVID-19 Convalescent Plasma
Herman, J. D., Wang, C., Loos, C., Yoon, H. a., Rivera, J., Dieterle, M. E., Haslwanter, D., Jangra, R. K., Bortz, R., Bar, K., Julg, B., Chandran, K., Pirofski, L.-a., Lauffenburger, D., Alter, G.
10.1101/2021.03.08.21253157 — Posted: 2021-03-11
Proteome-wide Mendelian randomization identifies causal links between blood proteins and severe COVID-19
Palmos, A. B., Millischer, V., Menon, D. K., Nicholson, T. R., Taams, L., Michael, B., COVID Clinical Neuroscience Study Consortium, , Huebel, C., Breen, G.
10.1101/2021.03.09.21253206 — Posted: 2021-03-11
Tiled-ClickSeq for targeted sequencing of complete coronavirus genomes with simultaneous capture of RNA recombination and minority variants
Routh, A. L., Jaworski, E., Langsjoen, R. M., Judy, B., Newman, P., Zhou, Y., Swetnam, D., Miller, A. L., Plante, J. A., Plante, K. S., Dong, J., Ren, P., Ksiazek, T., Menachery, V. D., Weaver, S.
10.1101/2021.03.10.434828 — Posted: 2021-03-11
Factors influencing COVID rates at local authority level and contribution of variation in vaccine coverage
Cullum, R., Badrinath, P.
10.1101/2021.03.08.21253144 — Posted: 2021-03-11
Determining the risk of developing symptomatic covid-19 infection after attending hospital for radiological examinations: controlled cohort study
Evangelou, N., Vaughan, S., Hibbert, A., Morgan, P., Backx, M., Berry, L., Card, T., Tallantyre, E.
10.1101/2021.03.08.21253143 — Posted: 2021-03-11

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).